← Evidence map

ArticlePharmacoEconomics & outcomes news2021

Specialty and cancer drugs set to drive US drug expenditure in 2021.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33948077